SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-014869
Filing Date
2022-08-04
Accepted
2022-08-04 17:12:46
Documents
65
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ymtx-20220630.htm   iXBRL 10-Q 3202932
2 EX-31.1 ymtx-ex31_1.htm EX-31.1 20893
3 EX-31.2 ymtx-ex31_2.htm EX-31.2 20961
4 EX-32.1 ymtx-ex32_1.htm EX-32.1 25797
  Complete submission text file 0000950170-22-014869.txt   10135427

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ymtx-20220630_def.xml EX-101.DEF 244681
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ymtx-20220630.xsd EX-101.SCH 61356
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ymtx-20220630_pre.xml EX-101.PRE 382266
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ymtx-20220630_lab.xml EX-101.LAB 538810
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ymtx-20220630_cal.xml EX-101.CAL 62132
59 EXTRACTED XBRL INSTANCE DOCUMENT ymtx-20220630_htm.xml XML 1712419
Mailing Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135
Business Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135 617-409-5300
YUMANITY THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37695 | Film No.: 221137710
SIC: 2834 Pharmaceutical Preparations